0
Following the launch of its patented bacterial phytase, Axtra® PHY, to the poultry sector earlier this year, DuPont subsidiary Danisco Animal Nutrition has achieved FDA agreement for a highly cost-effective lower Axtra® PHY dose level for swine (250 FTU/kg feed).
Axtra® PHY offers cost-effective dosing through use of a strong set of matrix values which are, in turn, supported by numerous worldwide trials at different production stages (weaner and grower/finisher). It is also more bio-efficacious than E.coliphytases, offering:
- Additional cost savings of ~$1.08 per metric tonne (~$0.98 per short ton) of pig feed through its ability to make available ~20% more phosphorus (P) and calcium (Ca) earlier in the digestive process.
- Availability of ~10% more digestible energy to the pig through superior phytate degradation in the upper gut.
- Additional manure management cost savings.
Axtra® PHY is available in liquid and dry product forms. If a dry product form is preferred, maximum performance and ease of use is ensured through its Thermo Protection Technology (TPT) granule, ensuring heat stability up to 203°F (95°C). Axtra®PHY benefits from strong support services, such as a FASTKit® assay which detects the presence of active Axtra® PHY in feed and a new online service, Optimize Feed™, which helps producers optimize diet formulations to ensure maximum cost savings.
Gwendolyn Jones, technical services manager at Danisco Animal Nutrition commented, “Pig producers are facing tough times because of market and feed cost volatility so anything that can save them buying more product than they need to achieve profitable results has to be good news. Axtra® PHY is the most advanced phytase technology on the market and its cost effectiveness at low dose is backed with solid, evidence based matrix values.”
November 7, 2013 - Danisco
